Abstract
A Phase II Study Evaluating the Combination of Nivolumab (Nivo) or Ipilimumab (Ipi) with Azacitidine in Pts with Previously Treated or Untreated Myelodysplastic Syndromes (MDS)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have